India Lung Cancer Therapeutic Market (2025-2031) | Analysis, Restraints, Revenue, Value, Competitive, Drivers, Demand, Pricing Analysis, Investment Trends, Outlook, Consumer Insights, Segmentation, Size, Forecast, Supply, Industry, Strategic Insights, Strategy, Share, Companies, Trends, Competition, Challenges, Segments, Opportunities, Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Lung Cancer Therapeutic Market Revenues & Volume, 2021 & 2031F

3.3 India Lung Cancer Therapeutic Market - Industry Life Cycle

3.4 India Lung Cancer Therapeutic Market - Porter's Five Forces

3.5 India Lung Cancer Therapeutic Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

3.6 India Lung Cancer Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.7 India Lung Cancer Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of lung cancer in India

4.2.2 Growing awareness about early detection and treatment options

4.2.3 Advancements in therapeutic technologies and treatments for lung cancer

4.3 Market Restraints

4.3.1 High cost of lung cancer treatments and therapies

4.3.2 Limited access to quality healthcare facilities in rural areas

4.3.3 Stringent regulatory processes for approval of new therapies

6.1 India Lung Cancer Therapeutic Market, By Therapy Type

6.1.1 Overview and Analysis

6.1.2 India Lung Cancer Therapeutic Market Revenues & Volume, By Therapy Type, 2021 - 2031F

6.1.3 India Lung Cancer Therapeutic Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F

6.1.4 India Lung Cancer Therapeutic Market Revenues & Volume, By Chemotherapy, 2021 - 2031F

6.1.5 India Lung Cancer Therapeutic Market Revenues & Volume, By Immunotherapy, 2021 - 2031F

6.1.6 India Lung Cancer Therapeutic Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F

6.1.7 India Lung Cancer Therapeutic Market Revenues & Volume, By Surgery, 2021 - 2031F

6.2 India Lung Cancer Therapeutic Market, By Drug Class

6.2.1 Overview and Analysis

6.2.2 India Lung Cancer Therapeutic Market Revenues & Volume, By Kinase Inhibitors, 2021 - 2031F

6.2.3 India Lung Cancer Therapeutic Market Revenues & Volume, By Platinum-based Drugs, 2021 - 2031F

6.2.4 India Lung Cancer Therapeutic Market Revenues & Volume, By PD-1/PD-L1 Inhibitors, 2021 - 2031F

6.2.5 India Lung Cancer Therapeutic Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F

6.3 India Lung Cancer Therapeutic Market, By End User

6.3.1 Overview and Analysis

6.3.2 India Lung Cancer Therapeutic Market Revenues & Volume, By Hospitals, 2021 - 2031F

6.3.3 India Lung Cancer Therapeutic Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F

6.3.4 India Lung Cancer Therapeutic Market Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031F

7.1 India Lung Cancer Therapeutic Market Export to Major Countries

7.2 India Lung Cancer Therapeutic Market Imports from Major Countries

8.1 Number of lung cancer cases diagnosed at early stages

8.2 Adoption rate of innovative lung cancer therapies

8.3 Number of research and development collaborations in the lung cancer therapeutic market

8.4 Patient survival rates post-treatment

8.5 Rate of patient referrals to specialized lung cancer treatment centers

9.1 India Lung Cancer Therapeutic Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

9.2 India Lung Cancer Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.3 India Lung Cancer Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 India Lung Cancer Therapeutic Market Revenue Share, By Companies, 2024

10.2 India Lung Cancer Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters